ProfileGDS5822 / ILMN_2821014
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 98% 98% 97% 98% 98% 98% 98% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 14030.498
GSM1276600PDAC Late Ablation Control 22898.298
GSM1276601PDAC Late Ablation Control 32160.197
GSM1276602PDAC Late Ablation 13504.498
GSM1276603PDAC Late Ablation 23219.498
GSM1276604PDAC Late Ablation 33310.698
GSM1303940PDAC Late Ablation_anti-CTLA4 13702.598
GSM1303941PDAC Late Ablation_anti-CTLA4 23542.898
GSM1303942PDAC Late Ablation_anti-CTLA4 33744.298